Adaptive Biotechnologies Corp (NASDAQ:ADPT)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ADPT

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ADPT

  • Market Cap$6.375bn
  • SymbolNASDAQ:ADPT
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS00650F1093

Company Profile

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Latest ADPT news

Currently there for this company. Visit our news hub for other news .